InMed Pharmaceuticals, Inc.
(NASDAQ : INM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -32.72%69.530.0%$388.91m
ICLRICON plc 1.11%243.272.8%$348.47m
VRXValeant Pharmaceuticals International, Inc. -1.18%29.2414.1%$172.05m
HZNPHorizon Therapeutics Plc -2.52%100.025.5%$112.77m
JAZZJazz Pharmaceuticals Plc -0.63%169.522.2%$84.19m
CTLTCatalent, Inc. 0.48%119.892.1%$76.78m
PRGOPerrigo Co. Plc 0.44%48.106.9%$48.96m
ENDPEndo International Plc 1.20%5.068.6%$46.03m
BHCBausch Health Cos., Inc. -1.18%29.240.0%$42.50m
ARGXargenx SE 2.90%304.430.0%$40.02m
UTHRUnited Therapeutics Corp. -1.24%181.9314.0%$39.35m
SAGESAGE Therapeutics, Inc. -0.91%43.737.6%$32.31m
NTECIntec Pharma Ltd. -16.68%11.290.0%$31.56m
IRWDIronwood Pharmaceuticals, Inc. 0.84%13.279.6%$25.32m
PLXPPLx Pharma, Inc. 0.21%18.730.1%$17.71m

Company Profile

InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.